SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 140 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2018. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $38,000 | -2.6% | 22,700 | 0.0% | 0.00% | – |
Q2 2018 | $39,000 | -4.9% | 22,700 | 0.0% | 0.00% | – |
Q1 2018 | $41,000 | -19.6% | 22,700 | 0.0% | 0.00% | – |
Q4 2017 | $51,000 | -13.6% | 22,700 | 0.0% | 0.00% | – |
Q3 2017 | $59,000 | -41.6% | 22,700 | 0.0% | 0.00% | – |
Q2 2017 | $101,000 | -3.8% | 22,700 | 0.0% | 0.00% | – |
Q1 2017 | $105,000 | -24.5% | 22,700 | 0.0% | 0.00% | – |
Q4 2016 | $139,000 | -44.4% | 22,700 | -50.0% | 0.00% | – |
Q3 2016 | $250,000 | +190.7% | 45,400 | +100.0% | 0.00% | – |
Q2 2016 | $86,000 | +38.7% | 22,700 | 0.0% | 0.00% | – |
Q1 2016 | $62,000 | -51.9% | 22,700 | 0.0% | 0.00% | – |
Q4 2015 | $129,000 | +7.5% | 22,700 | 0.0% | 0.00% | – |
Q3 2015 | $120,000 | -36.2% | 22,700 | 0.0% | 0.00% | -100.0% |
Q2 2015 | $188,000 | +80.8% | 22,700 | 0.0% | 0.00% | – |
Q1 2015 | $104,000 | +50.7% | 22,700 | 0.0% | 0.00% | – |
Q4 2014 | $69,000 | +9.5% | 22,700 | 0.0% | 0.00% | – |
Q3 2014 | $63,000 | -31.5% | 22,700 | 0.0% | 0.00% | – |
Q2 2014 | $92,000 | – | 22,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |